COMMUNIQUÉS West-GlobeNewswire

Sen. Debbie Stabenow, State Legislators to Highlight Annual Walk a Mile in My Shoes Rally & Warn Against State PIHP Procurement Process
04/09/2025
Stabenow, other state leaders to sound alarm against the competitive procurement process for prepaid inpatient health plans LANSING, Mich., Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Community Mental Health Association of [...]
BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
04/09/2025
Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO) NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE [...]
Lexicon Pharmaceuticals to Present New Preclinical Data on Pilavapadin in Chemotherapy-Induced Pain and Multiple Sclerosis Pain at NeuPSIG 2025
04/09/2025
THE WOODLANDS, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the Company will present new data demonstrating the reduction of neuropathic pain by pilavapadin [...]
Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management
04/09/2025
NPM-139 has potential to provide Wegovy ® -level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance [...]
TOMI Environmental Solutions to Present at the H.C. Wainwright Annual Global Investment Conference
04/09/2025
FREDERICK, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization [...]
CytoDyn Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
04/09/2025
VANCOUVER, Washington, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal [...]
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies
04/09/2025
Dr. Trieu’s prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast, pancreas and non-small cell lung cancer, among others Oncotelic’s robust portfolio and clinical pipeline is [...]
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
04/09/2025
Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistance Additional poster presentations [...]
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
04/09/2025
Leadership Team's Technical Primer Enhances Real-World Evidence (RWE) for Cross-Border Impact, Positioning Fifty1 AI Labs in a $48B Market Opportunity VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via [...]
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
04/09/2025
Novel human preclinical neuronal model for Parkinson’s disease demonstrated CNM-Au8’s ability to improve mitochondrial health, restore cellular metabolism, reduce inflammation, and normalize dysregulated gene expression [...]
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
04/09/2025
Internationally recognized vascular surgeon, Dr. Koen Deloose provides patient access to latest innovative treatments and personalized care BERKELEY, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or [...]
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
04/09/2025
Empowering BioLegacy to Lead Innovation in Combating the Opioid Epidemic Through Advanced Manufacturing and Research VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: [...]
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
04/09/2025
SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people [...]
Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside
04/09/2025
September 4, 2025 Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Cambridge, Massachusetts – Philips , a global [...]
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination
04/09/2025
PALO ALTO, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur”), a majority-owned subsidiary of Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue- [...]
Dyadic to Present at Investor Conferences and BPI East
04/09/2025
JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on [...]
LogicMark Becomes First to Integrate Medication Reminders into Medical Alert Technology
04/09/2025
Medication management and reminder feature launches in the Freedom Alert Max, eliminating the need for separate apps while providing a comprehensive safety solution for seniors and caregivers LOUISVILLE, Ky., Sept. 04, [...]
“He’s No Prince” PSA Shatters Fairy Tale Illusions to Expose Emotional Abuse
04/09/2025
Safe in Harm’s Way and Neon, an IPG Health company, Unveil Final Installment in Award-Winning Domestic Violence Billboard Series NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- What if Prince Charming wasn’t so charming [...]
VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
04/09/2025
— Presentations spotlight VIVUS’s 13-year track record of leadership with QSYMIA® (phentermine and topiramate extended-release capsules CIV) in the treatment of obesity and overweight CAMPBELL, Calif., Sept. 04, 2025 ( [...]

Pages